Hemab Therapeutics Company Profile, Contacts & Intelligence

Hemab Therapeutics Overview

Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Based in Cambridge, Massachusetts and Copenhagen, Denmark, Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company’s strategic guidance, Hemab 1-2-5, targets the development of 5 clinical assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood clotting disorders like Glanzmann Thrombasthenia, factor VII deficiency, Bernard Soulier Syndrome, Von Willebrand Disease and other serious disorders. Learn more at hemab.com.

Headquarters

Copenhagen, Dk

Website

www.hemab.com

Industry

Biotechnology Research

Founded

2019

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Hemab Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Hemab Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to Hemab Therapeutics

Explore companies in related markets and compare their industry and employee estimates.